Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity.

Auteurs : Awada A, Dumez H, Aftimos P, Costermans J, Bartholomeus S, Forceville K, Berghmans T, Meeus MA, Cescutti J, Munzert G, Pilz K, Liu D, Schöffski P
Jaar : 2015
Journal : Invest New Drugs
Volume : 33(3)
Pagina's : 611-20